Brief: Amphastar Pharmaceuticals Receives FDA Approval For Morphine Sulfate Injection
03/05/2021 13:09
May 3 (Reuters) - Amphastar Pharmaceuticals Inc AMPH.O :
* AMPHASTAR PHARMACEUTICALS RECEIVES FDA APPROVAL FOR
MORPHINE
SULFATE INJECTION
Source text for Eikon: ID:nGNX2SwtZ2
Further company coverage: AMPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amphastar Pharmaceuticals
See all newsAmphastar Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Amphastar Pharmaceuticals Q2 EPS USD 0.67
U.S. STOCKS ON THE MOVE-RBB Bancorp, Roblox, Open Lending
U.S. STOCKS ON THE MOVE-Amkor Technology, Dynatrace, Corvex
Amphastar rises after FDA approves new over-the-counter overdose spray